David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
Kennedy Institute of Ethics Journal 19 (1):pp. 1-22 (2009)
Direct reprogramming of human skin cells makes available a source of pluripotent stem cells without the perceived evil of embryo destruction, but the advent of such a powerful biotechnology entangles stem cell research in other forms of moral complicity. Induced pluripotent stem cell (iPSC) research had its origins in human embryonic stem cell research and the projected biomedical applications of iPS cells almost certainly will require more embryonic stem cell research. Policies that inhibit iPSC research in order to avoid moral complicity are themselves complicit in preventable harms to patients. Moral complicity may be unavoidable, but a Blue Ribbon Panel charged with assessing the need for additional embryonic stem cell lines may ease a transition from embryonic stem cell research to clinical applications of iPS cells.
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
No references found.
Citations of this work BETA
No citations found.
Similar books and articles
W. Malcolm Byrnes & Edward J. Furton (2009). Comments on “Moral Complicity in Induced Pluripotent Stem Cell Research”. Kennedy Institute of Ethics Journal 19 (2):202-205.
W. Malcolm Byrnes Edward J. Furton (2009). Comments on “Moral Complicity in Induced Pluripotent Stem Cell Research”. Kennedy Institute of Ethics Journal 19 (2):pp. 202-205.
Hossam E. Fadel (2012). Developments in Stem Cell Research and Therapeutic Cloning: Islamic Ethical Positions, a Review. Bioethics 26 (3):128-135.
Bernard Dickens, International Society for Stem Cell Research (ISSCR) Guidelines for the Conduct of Human Embryonic Stem Cell Research (December 2006).
John A. Robertson (1999). Ethics and Policy in Embryonic Stem Cell Research. Kennedy Institute of Ethics Journal 9 (2):109-136.
Mark Brown (2013). No Ethical Bypass of Moral Status in Stem Cell Research. Bioethics 27 (1):12-19.
Katrien Devolder & John Harris (2005). Compromise and Moral Complicity in the Embryonic Stem Cell Debate. In Nafsika Athanassoulis (ed.), Philosophical Reflections on Medical Ethics. Palgrave Macmillan.
Nikolaus Knoepffler (2004). Stem Cell Research: An Ethical Evaluation of Policy Options. Kennedy Institute of Ethics Journal 14 (1):55-74.
Ronald K. F. Fung & Ian H. Kerridge (2013). Uncertain Translation, Uncertain Benefit and Uncertain Risk: Ethical Challenges Facing First-in-Human Trials of Induced Pluripotent Stem (Ips) Cells. Bioethics 27 (2):89-96.
Zubin Master & G. K. D. Crozier (2012). The Ethics of Moral Compromise for Stem Cell Research Policy. Health Care Analysis 20 (1):50-65.
Added to index2009-03-11
Total downloads197 ( #2,984 of 1,103,039 )
Recent downloads (6 months)7 ( #36,701 of 1,103,039 )
How can I increase my downloads?